Melphalan-total body irradiation and allogeneic transplantation from HLA-identical siblings for acute myeloid leukemia in first remission: Higher relapse after marrow-derived stem cell grafts compared to blood despite similar chronic graft-versus-host disease.

被引：0
|
作者：
Sirohi, B
Powles, R
Singhal, S
Treleaven, J
Horton, C
Tait, D
Kulkarni, S
Saso, R
Mehta, J
机构：
[1] Royal Marsden Hosp, Surrey, England
[2] Northwestern Univ, Sch Med, Chicago, IL USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5305
引用
收藏
页码：381B / 381B
页数：1
相关论文
共 50 条
  • [31] Graft-versus-host Disease-free, Relapse-free Survival After HLA-identical Sibling Peripheral Blood Stem Cell Transplantation With Tacrolimus-based Graft-versus-host Disease Prophylaxis in Japanese Patients
    Shingaki, S.
    Tsukada, N.
    Ikeda, M.
    Suzuki, K.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (01) : 241 - 245
  • [32] Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation
    Atkinson, K
    Downs, K
    BONE MARROW TRANSPLANTATION, 1995, 16 (06) : 755 - 758
  • [33] Refined Graft-Versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate and Unfavorable Prognosis Acute Myeloid Leukemia Ttransplanted in First Complete Remission from HLA-Identical Related or Unrelated Donors: A Retrospective Study on Behalf of the ALWP of the EBMT
    Battipaglia, Giorgia
    Ruggeri, Annalisa
    Labopin, Myriam
    Volin, Liisa
    Blaise, Didier
    Socie, Gerard
    Milpied, Noel
    Cornelissen, Jan J.
    Ghavamzadeh, Ardeshir
    Huynh, Anne
    Wu Depei
    Yakoub-Agha, Ibrahim
    Maertens, Johan
    Chevallier, Patrice
    Mohty, Mohamad
    Nagler, Arnon
    BLOOD, 2016, 128 (22)
  • [34] Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation
    F Baron
    M Labopin
    D Niederwieser
    S Vigouroux
    J J Cornelissen
    C Malm
    L L Vindelov
    D Blaise
    J J W M Janssen
    E Petersen
    G Socié
    A Nagler
    V Rocha
    M Mohty
    Leukemia, 2012, 26 : 2462 - 2468
  • [35] Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation
    Baron, F.
    Labopin, M.
    Niederwieser, D.
    Vigouroux, S.
    Cornelissen, J. J.
    Malm, C.
    Vindelov, L. L.
    Blaise, D.
    Janssen, J. J. W. M.
    Petersen, E.
    Socie, G.
    Nagler, A.
    Rocha, V.
    Mohty, M.
    LEUKEMIA, 2012, 26 (12) : 2462 - 2468
  • [36] High doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation.
    Mohty, M
    Bilger, K
    Jourdan, E
    Kuentz, M
    Michallet, M
    Bourhis, JH
    Milpied, N
    Sutton, L
    Jouet, JP
    Blaise, D
    BLOOD, 2002, 100 (11) : 848A - 848A
  • [37] Improved disease-free-survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients with first chronic phase chronic myeloid leukemia
    Elmaagacli, AH
    Basoglu, S
    Peceny, R
    Trenschel, R
    Ottinger, H
    Lollert, A
    Runde, V
    Grosse-Wilde, H
    Beelen, DW
    Schaefer, UW
    BLOOD, 2002, 99 (04) : 1130 - 1135
  • [38] Improved disease free survival after transplantation of peripheral blood stem cells as compared to bone marrow from HLA-identical unrelated donors in patients with first chronic phase chronic myeloid leukemia.
    Elmaagacli, AH
    Peceny, R
    Semiha, B
    Rudolf, T
    Ottinger, H
    Scheulen, M
    Beelen, DW
    Schaefer, UW
    BLOOD, 2001, 98 (11) : 673A - 673A
  • [39] MINIMAL RESIDUAL DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA IN 1ST CHRONIC PHASE - CORRELATIONS WITH ACUTE GRAFT-VERSUS-HOST DISEASE AND RELAPSE
    CROSS, NCP
    HUGHES, TP
    FENG, L
    OSHEA, P
    BUNGEY, J
    MARKS, DI
    FERRANT, A
    MARTIAT, P
    GOLDMAN, JM
    BRITISH JOURNAL OF HAEMATOLOGY, 1993, 84 (01) : 67 - 74
  • [40] Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: A meta-analysis
    Cutler, C
    Giri, S
    Jeyapalan, S
    Paniagua, D
    Viswanathan, A
    Antin, JH
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) : 3685 - 3691
12345